Studies on the mechanism of the antifertility activity of Human Chorionic Gonadotropin in rodents

D. W. Hahn, Laurence Demers, J. L. McGuire

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Administration of 2.0 IU (3300 IU/mg) Human Chorionic Gonadotropin (hCG) to rats on days 7 to 13 of pregnancy induced complete embryonic resorption. This commercial preparation was also active in the mouse and hamster at 20 and 50 IUs per animal per day, respectively. It was inactive in the rat when administered after day 13 of pregnancy. Studies to determine how hCG could exert this effect resulted in the following findings: Concomitant administration of progesterone (8 mg/rat) to ovariectomized pregnant rats reduced the antifertility activity of hCG. Little or no estrogen could be identified by radioimmunoassay in the hCG preparations which had antifertility activity. The antifertility activity was, however, found associated with a molecular fraction which could be destroyed by both boiling and treatment with pronase, and which cross-reacted with anti-hCG. The antifertility activity of hCG was abolished by anti-hCG. Finally, serum estrogen levels in pregnant rats were found to be elevated by treatment with hCG.

Original languageEnglish (US)
Pages (from-to)551-560
Number of pages10
JournalContraception
Volume21
Issue number5
DOIs
StatePublished - Jan 1 1980

Fingerprint

Chorionic Gonadotropin
Rodentia
Estrogens
Pregnancy
Pronase
Cricetinae
Radioimmunoassay
Progesterone
Serum

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Hahn, D. W. ; Demers, Laurence ; McGuire, J. L. / Studies on the mechanism of the antifertility activity of Human Chorionic Gonadotropin in rodents. In: Contraception. 1980 ; Vol. 21, No. 5. pp. 551-560.
@article{e983ca407c7f4790a1079dc7890adddd,
title = "Studies on the mechanism of the antifertility activity of Human Chorionic Gonadotropin in rodents",
abstract = "Administration of 2.0 IU (3300 IU/mg) Human Chorionic Gonadotropin (hCG) to rats on days 7 to 13 of pregnancy induced complete embryonic resorption. This commercial preparation was also active in the mouse and hamster at 20 and 50 IUs per animal per day, respectively. It was inactive in the rat when administered after day 13 of pregnancy. Studies to determine how hCG could exert this effect resulted in the following findings: Concomitant administration of progesterone (8 mg/rat) to ovariectomized pregnant rats reduced the antifertility activity of hCG. Little or no estrogen could be identified by radioimmunoassay in the hCG preparations which had antifertility activity. The antifertility activity was, however, found associated with a molecular fraction which could be destroyed by both boiling and treatment with pronase, and which cross-reacted with anti-hCG. The antifertility activity of hCG was abolished by anti-hCG. Finally, serum estrogen levels in pregnant rats were found to be elevated by treatment with hCG.",
author = "Hahn, {D. W.} and Laurence Demers and McGuire, {J. L.}",
year = "1980",
month = "1",
day = "1",
doi = "10.1016/0010-7824(80)90018-9",
language = "English (US)",
volume = "21",
pages = "551--560",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "5",

}

Studies on the mechanism of the antifertility activity of Human Chorionic Gonadotropin in rodents. / Hahn, D. W.; Demers, Laurence; McGuire, J. L.

In: Contraception, Vol. 21, No. 5, 01.01.1980, p. 551-560.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Studies on the mechanism of the antifertility activity of Human Chorionic Gonadotropin in rodents

AU - Hahn, D. W.

AU - Demers, Laurence

AU - McGuire, J. L.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - Administration of 2.0 IU (3300 IU/mg) Human Chorionic Gonadotropin (hCG) to rats on days 7 to 13 of pregnancy induced complete embryonic resorption. This commercial preparation was also active in the mouse and hamster at 20 and 50 IUs per animal per day, respectively. It was inactive in the rat when administered after day 13 of pregnancy. Studies to determine how hCG could exert this effect resulted in the following findings: Concomitant administration of progesterone (8 mg/rat) to ovariectomized pregnant rats reduced the antifertility activity of hCG. Little or no estrogen could be identified by radioimmunoassay in the hCG preparations which had antifertility activity. The antifertility activity was, however, found associated with a molecular fraction which could be destroyed by both boiling and treatment with pronase, and which cross-reacted with anti-hCG. The antifertility activity of hCG was abolished by anti-hCG. Finally, serum estrogen levels in pregnant rats were found to be elevated by treatment with hCG.

AB - Administration of 2.0 IU (3300 IU/mg) Human Chorionic Gonadotropin (hCG) to rats on days 7 to 13 of pregnancy induced complete embryonic resorption. This commercial preparation was also active in the mouse and hamster at 20 and 50 IUs per animal per day, respectively. It was inactive in the rat when administered after day 13 of pregnancy. Studies to determine how hCG could exert this effect resulted in the following findings: Concomitant administration of progesterone (8 mg/rat) to ovariectomized pregnant rats reduced the antifertility activity of hCG. Little or no estrogen could be identified by radioimmunoassay in the hCG preparations which had antifertility activity. The antifertility activity was, however, found associated with a molecular fraction which could be destroyed by both boiling and treatment with pronase, and which cross-reacted with anti-hCG. The antifertility activity of hCG was abolished by anti-hCG. Finally, serum estrogen levels in pregnant rats were found to be elevated by treatment with hCG.

UR - http://www.scopus.com/inward/record.url?scp=0018820255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018820255&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(80)90018-9

DO - 10.1016/0010-7824(80)90018-9

M3 - Article

C2 - 7428363

AN - SCOPUS:0018820255

VL - 21

SP - 551

EP - 560

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -